BioCentury
ARTICLE | Clinical News

IV rigosertib: Additional Phase III data

July 13, 2015 7:00 AM UTC

Onconova Therapeutics Inc. (NASDAQ:ONTX), Newton, Pa. SymBio Pharmaceuticals Ltd. (JASDAQ:4582), Tokyo, Japan Product: IV rigosertib ( Estybon, SyB L-1101)) ( ON 01910.Na) Business: Cancer Molecular...